Rain Therapeutics
Stock Forecast, Prediction & Price Target
Rain Therapeutics Financial Estimates
Rain Therapeutics Revenue Estimates
Rain Therapeutics EBITDA Estimates
Rain Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-19.19M N/A | $-51.39M -167.73% | $-75.72M -47.34% | Avg: $-23.57M Low: $-20.14M High: $-13.71M avg. 68.86% | |||
EBITDA
% change YoY
| $-18.90M N/A | $-51.39M -171.82% | $-77.13M -50.09% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$1.8 N/A | -$2.65 -47.22% | -$2.71 -2.26% | Avg: -$0.66 Low: -$0.72 High: -$0.49 avg. 75.55% | |||
Operating Expenses
% change YoY
| $18.95M N/A | $51.51M 171.71% | $77.13M 49.74% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Rain Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 68.86% in 2025-2025.
We have gathered data from 4 analysts. Their low estimate is -20.14M, average is -23.57M and high is -13.71M.
What is Rain Therapeutics stock revenue growth forecast?
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Rain Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 75.55% in 2025-2025.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.72, average is -$0.66 and high is $-0.49.